QFR (3.0)

FDA 510(k) K243769 · Qfr Solutions BV

Substantially Equivalent

510(k) numberK243769

Submission

Device name
QFR (3.0)
Applicant
Qfr Solutions BV
Leiden, NL
Received
December 6, 2024
Decision date
April 4, 2025
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QHA – X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
Device class
Class II (moderate risk)
Regulation
21 CFR 892.1600
Specialty
Radiology

X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology…

Other 510(k)s with product code QHA

510(k)DeviceApplicantDecision
K251355X1-FFRQHA · Traditional Spectrawave, Inc.10/17/2025SE
K232147CAAS WorkstationQHA · Traditional Pie Medical Imaging BV04/09/2024SE
K230303AccuFFRangio PlusQHA · Special ArteryFlow Technology Co., Ltd.03/02/2023SE
K221711AccuICASQHA · Traditional ArteryFlow Technology Co., Ltd.02/28/2023SE
K210093AccuFFRangioQHA · Traditional ArteryFlow Technology Co., Ltd.09/10/2021SE
K182611Qangio XA 3DQHA · Traditional Medis Medical Imaging Systems BV05/30/2019SE

Questions and answers

When was QFR (3.0) cleared by the FDA?

QFR (3.0) (K243769) received a 510(k) decision of Substantially Equivalent on April 4, 2025, 119 days after the submission was received.

What is the product code of K243769?

The FDA product code is QHA – X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device, a Class II (moderate risk) device regulated under 21 CFR 892.1600.